Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Antithrombotic strategies post-TAVI remain uncertain; leaves open optimal regimen balancing ischemic and bleeding risks.
Gargiulo et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: